Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 16(2): e0246803, 2021.
Article in English | MEDLINE | ID: mdl-33571320

ABSTRACT

Niclosamide (NIC) has demonstrated promising in vitro antiviral efficacy against SARS-CoV-2, the causative agent of the COVID-19 pandemic. Though NIC is already FDA-approved, administration of the currently available oral formulation results in systemic drug levels that are too low for the inhibition of SARS-CoV-2. We hypothesized that the co-formulation of NIC with an endogenous protein, human lysozyme (hLYS), could enable the direct aerosol delivery of the drug to the respiratory tract as an alternative to oral delivery, thereby effectively treating COVID-19 by targeting the primary site of SARS-CoV-2 acquisition and spread. To test this hypothesis, we engineered and optimized composite particles containing NIC and hLYS suitable for delivery to the upper and lower airways via dry powder inhaler, nebulizer, and nasal spray. The novel formulation demonstrates potent in vitro and in vivo activity against two coronavirus strains, MERS-CoV and SARS-CoV-2, and may offer protection against methicillin-resistance staphylococcus aureus pneumonia and inflammatory lung damage occurring secondary to SARS-CoV-2 infections. The suitability of the formulation for all stages of the disease and low-cost development approach will ensure rapid clinical development and wide-spread utilization.


Subject(s)
Antiviral Agents/administration & dosage , Coronavirus Infections/drug therapy , Muramidase/administration & dosage , Niclosamide/administration & dosage , Administration, Inhalation , Animals , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Cell Line , Drug Compounding , Drug Delivery Systems/instrumentation , Dry Powder Inhalers , Humans , Mice, Transgenic , Middle East Respiratory Syndrome Coronavirus/drug effects , Muramidase/pharmacology , Muramidase/therapeutic use , Nasal Sprays , Niclosamide/pharmacology , Niclosamide/therapeutic use , SARS-CoV-2/drug effects , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL
...